Anvisa unregisters the crossfire Plus and prohibits advertising nationwide
This article was translated by an automatic translation system, and was therefore not reviewed by people.
Formula medicine against cramps is different from the crossfire "original".
According to the agency, the adjective "plus" could cause confusion
The National Health Surveillance Agency (Anvisa) canceled the registration of the drug crossfire Plus, the company Hypermarcas S / A. The drug can no longer be sold in Brazil and the advertisements of the product were also suspended.
The cancellation of registration crossfire Plus was motivated by no identity of wording between him and the drug compound crossfire. The active ingredient in crossfire Plus is paracetamol and the Composite, dipyrone. The adjective "plus", according to Anvisa, led the consumer to be deceived into believing in a potentiation of the effects of the drug compound.
Source: G1
This article was translated by an automatic translation system, and was therefore not reviewed by people.
Important:
The JurisWay site does not interfere in the work provided by doctrine, why only reflect the opinions, ideas and concepts of their authors.
